|
Volumn 39, Issue 4, 2001, Pages 245-250
|
Activity of BMS284756 against 2,681 recent clinical isolates of Haemophilus influenzae and Moraxella catarrhalis: Report from The SENTRY Antimicrobial Surveillance Program (2000) in Europe, Canada and the United States
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
AZITHROMYCIN;
CEFDINIR;
CEFPODOXIME;
CEFPROZIL;
CEFUROXIME;
CHLORAMPHENICOL DERIVATIVE;
CIPROFLOXACIN;
CLARITHROMYCIN;
COTRIMOXAZOLE;
DESFLUORO(6)QUINOLONE;
GARENOXACIN;
GATIFLOXACIN;
LEVOFLOXACIN;
LORACARBEF;
MOXIFLOXACIN;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
RIFAMPICIN;
TETRACYCLINE DERIVATIVE;
UNCLASSIFIED DRUG;
ANTIBIOTIC RESISTANCE;
ANTIMICROBIAL ACTIVITY;
ARTICLE;
BACTERIUM DETECTION;
BACTERIUM ISOLATION;
CANADA;
CONTROLLED STUDY;
DEVICE;
DIAGNOSTIC ACCURACY;
DRUG POTENCY;
DRUG SURVEILLANCE PROGRAM;
EUROPE;
HAEMOPHILUS INFLUENZAE;
INTERMETHOD COMPARISON;
MINIMUM INHIBITORY CONCENTRATION;
MORAXELLA CATARRHALIS;
NONHUMAN;
PRIORITY JOURNAL;
UNITED STATES;
ANTI-INFECTIVE AGENTS;
AZA COMPOUNDS;
CANADA;
CIPROFLOXACIN;
EUROPE;
FLUOROQUINOLONES;
HAEMOPHILUS INFLUENZAE;
HUMANS;
INDOLES;
MICROBIAL SENSITIVITY TESTS;
MORAXELLA (BRANHAMELLA) CATARRHALIS;
OFLOXACIN;
QUINOLINES;
QUINOLONES;
UNITED STATES;
|
EID: 0034993119
PISSN: 07328893
EISSN: None
Source Type: Journal
DOI: 10.1016/S0732-8893(01)00224-3 Document Type: Article |
Times cited : (25)
|
References (16)
|